Abvc Biopharma (ABVC) Net Equity Issued and Repurchased (2011 - 2026)
Abvc Biopharma (ABVC) reported Net Equity Issued and Repurchased of -$217,492 for Q2 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abvc Biopharma's Net Equity Issued and Repurchased came in at $3 million, up 210.4% year-over-year; for FY2025, it came in at $3.31 million, up 248.8% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -15.4% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $947,500 in FY2024 (-60.6%), $2.41 million in FY2023 (-34.3%), $3.66 million in FY2022 (-67.0%) and $11.12 million in FY2021 (+46.0%).
- The Q2 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since Q4 2022.
- Year over year, Net Equity Issued and Repurchased gained in three of the last four quarters, with growth averaging 180.6%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $319,492 (Q1 2026), $528,183 (Q4 2025) and $2.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | -217,492.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -217,492.00 |
| Mar 31, 2026 | 319,492.00 |
| Dec 31, 2025 | 528,183.00 |
| Sep 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 411,667.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | 343,429.00 |
| Mar 31, 2024 | 394,071.00 |
| Dec 31, 2023 | -22,690.00 |
| Dec 31, 2022 | -253,500.00 |
| Sep 30, 2022 | 253,500.00 |
| Dec 31, 2021 | 4.24 Mn |
| Mar 31, 2021 | 40,448.00 |
| Dec 31, 2020 | 5.46 Mn |
| Sep 30, 2020 | 456,180.00 |
| Jun 30, 2020 | 1.43 Mn |
| Mar 31, 2020 | 267,740.00 |
| Mar 31, 2019 | 531,147.00 |
| Sep 30, 2016 | 1.45 Mn |
| Sep 30, 2015 | 948,959.00 |
API Access
Abvc Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();